MRSA - Articles and news items

Eczema wounds diseased by S. aureus contamination

Industry news / 5 August 2016 / Erasmus MC University

A new study has revealed that 70% of eczema patients are colonised with Staphylococcus aureus bacteria (S. aureus, including MRSA) on their skin lesions…

MRSA treatment market to experience limited growth, says GlobalData

Industry news / 5 January 2016 / Victoria White

The minimal increase over the next decade will be largely the product of a treatment space dominated by three primary agents, namely vancomycin, Zyvox (linezolid), and Cubicin (daptomycin)…

Aridis expands Phase 2a trial of AR-301 into the US

Industry news / 9 July 2015 / Victoria White

The US Food and Drug Administration (FDA) has accepted Aridis Pharmaceuticals’ Investigational New Drug (IND) application for AR-301 (Salvecin)…

MIcreos

Changing the way we combat bacterial infections: Dutch biotech Micreos launches first bacteria-killing enzyme for human use against MRSA

Industry news / 5 November 2014 / Micreos

Micreos, a Dutch biotech company, has developed Staphefekt™, a bacteria-killing enzyme specific to Staphylococcus aureus, which is equally effective in killing methicillin-resistant Staphylococcus aureus (MRSA) as methicillin-susceptible Staphylococcus aureus (MSSA)…

Professor Dame Sally Davies, England’s Chief Medical Officer

Antimicrobial resistance poses ‘catastrophic threat’

Industry news, News / 12 March 2013 / Department of Health

Chief Medical Officer says global action is needed otherwise in 20 years we could see any one of us dying following minor surgery…

 

The deadline for submissions to the EPR Awards is 9 June 2017! Entry is FREE, so don't delay...
+